Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.
By S. Mehta, C. Cannon, K. Fox, L. Wallentin, W. Boden, R. Spacek, P. Widimsky, P. McCullough, D. Hunt, E. Braunwald and 1 more. Journal of the American Medical Association (JAMA), 2005
864 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/daf8a29f2666061ef3708889db81916b0663dae0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Radiology, Nuclear Medicine and Imaging
In Surgery
Citations in the corpus
- Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. (2007, neutral): “Former 579 (24) 467 (23) 1411 (31) 1168 (32)”
- Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. (2006, result): “These characteristics and the trial design increased the risk profile of the patients in this trial and should be taken into account when making comparisons between this and other trials in patients with ACS.7,22,23 Special consideration should be given to the C7E3 Fab Antiplatelet Therapy in Unstab”
- Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. (2007, background): “Recent systematic reviews of RCTs assessing routine invasive vs conservative therapies found between 8% and 21% improved relative survival in the more invasively-treated group.(4,5) Due to the complexity and cost of performing RCTs, there is interest in using observational studies to guide policy st”
- 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008, background): “(47) concluded that the routine invasive strategy resulted n an 18% relative reduction in death or MI, including a ignificant reduction in MI alone.”